🔗 Share this article

An underground market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with numerous of members share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers promote the substance there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Express Worries

However, physicians and chemists have warned that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Several experts stated the demand for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Material Elimination

According to TikTok, the service has removed problematic content and banned associated hashtags and search suggestions. The organization said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Trading Activities

Research also found groups with up to nine thousand members marketing the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly displays channels with numerous of users, filled with photos of weight loss, glowing testimonials and step-by-step guides for preparing or administering at residence.

Within moments of joining one community, a seller posted contact information, where the majority of transactions take place. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, health issues or previous experience.

Item Information and Costs

Within these communities, messages show black plastic parcels with postal service stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how much time a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A representative for Telegram stated it actively moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these digital products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has previously seen patients injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may expose patients to possibly significant medical dangers”.